Endpoints News
Company faced blowback after announcing compounded version of Novo's Wegovy pill Read in browser
Endpoints News
ALERT
Thank you for reading, dupa dupackia!
basic
UPGRADE
Breaking News

The tele­health com­pa­ny Hims & Hers said it will no longer sell a com­pound­ed ver­sion of No­vo Nordisk's We­govy pill, just days af­ter an­nounc­ing the new prod­uct...

Read the full story
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times